QualityStocks

[QualityStocks]

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Enters Supply and Clinic Services Agreements with Medical Cannabis by Shoppers(TM)

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) and its subsidiaries have entered into both a product supply agreement and a clinic services agreement with Medical Cannabis by Shoppers(TM). Under the supply agreement, VIVO’s licensed producers will offer a broad portfolio of Canna Farms(TM) and Beacon Medical(TM) branded medical cannabis products through the Medical Cannabis by Shoppers(TM) online sales platform, accessible to patients across Canada. “We have a six-year track record of cultivating and producing high-quality, medical-grade cannabis and are thrilled to partner with Shoppers Drug Mart Inc.” Barry Fishman, CEO of VIVO, said in the news release. “VIVO is extremely committed to the medical cannabis market. We are pleased to be able to leverage the insights learned from over 100,000 patient visits to our Harvest Medicine clinics and telemedicine platform. As we continue to invest in product development to expand our medical cannabis product line and satisfy unmet patient needs, we are excited by the prospect of introducing our novel future offerings to Medical Cannabis by Shoppers™ patients.”

To view the full press release, visit http://ibn.fm/mxyQd

About VIVO Cannabis(TM)
VIVO Cannabis(TM) is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms(TM), Beacon Medical(TM), Fireside(TM), Fireside-X(TM), Lumina(TM) and Canadian Bud Collection(TM). The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. The Company has a healthy balance sheet and is well-positioned to accelerate its path to profitability. For more information, visit www.VIVOCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF